Petrides, PE; Gisslinger, H; Steurer, M; Linkesch, H; Krumpl, G; Schuller, A; Widmann, R.
Differences in tolerability of two commercial anagrelide formulations may be caused by differences in bioavailability
HAEMATOL-HEMATOL J. 2007; 92: 244-244.
[Poster]
Web of Science